skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Selective high-affinity polydentate ligands and methods of making such

Abstract

This invention provides novel polydentate selective high affinity ligands (SHALs) that can be used in a variety of applications in a manner analogous to the use of antibodies. SHALs typically comprise a multiplicity of ligands that each bind different region son the target molecule. The ligands are joined directly or through a linker thereby forming a polydentate moiety that typically binds the target molecule with high selectivity and avidity.

Inventors:
; ;
Issue Date:
Research Org.:
Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1419794
Patent Number(s):
9,884,070
Application Number:
12/988,801
Assignee:
Lawrence Livermore National Security, LLC (Livermore, CA); The Regents of the University of California (Oakland, CA)
DOE Contract Number:  
AC52-07NA27344
Resource Type:
Patent
Resource Relation:
Patent File Date: 2009 Apr 21
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 60 APPLIED LIFE SCIENCES

Citation Formats

Denardo, Sally J., Denardo, Gerald L., and Balhorn, Rodney L. Selective high-affinity polydentate ligands and methods of making such. United States: N. p., 2018. Web.
Denardo, Sally J., Denardo, Gerald L., & Balhorn, Rodney L. Selective high-affinity polydentate ligands and methods of making such. United States.
Denardo, Sally J., Denardo, Gerald L., and Balhorn, Rodney L. Tue . "Selective high-affinity polydentate ligands and methods of making such". United States. https://www.osti.gov/servlets/purl/1419794.
@article{osti_1419794,
title = {Selective high-affinity polydentate ligands and methods of making such},
author = {Denardo, Sally J. and Denardo, Gerald L. and Balhorn, Rodney L.},
abstractNote = {This invention provides novel polydentate selective high affinity ligands (SHALs) that can be used in a variety of applications in a manner analogous to the use of antibodies. SHALs typically comprise a multiplicity of ligands that each bind different region son the target molecule. The ligands are joined directly or through a linker thereby forming a polydentate moiety that typically binds the target molecule with high selectivity and avidity.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2018},
month = {2}
}

Patent:

Save / Share:

Works referenced in this record:

Selective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia
journal, September 2007


Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells
journal, January 2009

  • Balhorn, Rod; Hok, Saphon; DeNardo, Sally
  • Molecular Cancer, Vol. 8, Article No. 25
  • DOI: 10.1186/1476-4598-8-25

Identification of Novel Small Molecules That Bind to Two Different Sites on the Surface of Tetanus Toxin C Fragment
journal, October 2002

  • Cosman, Monique; Lightstone, Felice C.; Krishnan, V. V.
  • Chemical Research in Toxicology, Vol. 15, Issue 10, p. 1218-1228
  • DOI: 10.1021/tx025570m

Nanomolecular HLA-DR10 Antibody Mimics: A Potent System for Molecular Targeted Therapy and Imaging
journal, December 2008

  • DeNardo, Gerald L.; Natarajan, Arutselvan; Hok, Saphon
  • Cancer Biotherapy and Radiopharmaceuticals, Vol. 23, Issue 6, p. 783-795
  • DOI: 10.1089/cbr.2008.0589

Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma
journal, August 2007

  • DeNardo, G. L.; Natarajan, A.; Hok, S.
  • Journal of Nuclear Medicine, Vol. 48, Issue 8, p. 1338-1347
  • DOI: 10.2967/jnumed.107.041095

Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma
journal, October 2007

  • DeNardo, Gerald; Hok, Saphon; Natarajan, Arutselvan
  • International Journal of Oncology, Vol. 31, Issue 4, p. 729-740
  • DOI: 10.3892/ijo.31.4.729

Update: Systemic Radiotherapy Can Cure Lymphoma: A Paradigm for Other Malignancies?
journal, August 2008

  • Denardo, Gerald L.; Denardo, Sally J.; Balhorn, Rod
  • Cancer Biotherapy and Radiopharmaceuticals, Vol. 23, Issue 4, p. 383-398
  • DOI: 10.1089/cbr.2007.0523-U

AB5 toxins: structures and inhibitor design
journal, December 2000

  • Fan, Erkang; Merritt, Ethan A.; Verlinde, Christophe L. M. J.
  • Current Opinion in Structural Biology, Vol. 10, Issue 6, p. 680-686
  • DOI: 10.1016/S0959-440X(00)00152-4

Bioaffinity NMR Spectroscopy: Identification of an E-Selectin Antagonist in a Substance Mixture by Transfer NOE
journal, January 1999


Synthesis and Radiolabeling of Selective High-Affinity Ligands Designed to Target Non-Hodgkin's Lymphoma and Leukemia
journal, May 2007

  • Hok, Saphon; Natarajan, Arutselvan; Balhorn, Rod
  • Bioconjugate Chemistry, Vol. 18, Issue 3, p. 912-921
  • DOI: 10.1021/bc060305o

Humanization and characterization of the anti-HLA-DR antibody 1D10
journal, January 2001

  • Kostelny, Sheri A.; Link, Brian K.; Tso, J. Yun
  • International Journal of Cancer, Vol. 93, Issue 4, p. 556-565
  • DOI: 10.1002/ijc.1366

Spanning binding sites on allosteric proteins with polymer-linked ligand dimers
journal, October 1998

  • Kramer, Richard H.; Karpen, Jeffrey W.
  • Nature, Vol. 395, Issue 6703, p. 710-713
  • DOI: 10.1038/27227

Structure-Based Design of a Bispecific Receptor Mimic That Inhibits T Cell Responses to a Superantigen
journal, April 2001

  • Lehnert, Nancy M.; Allen, David L.; Allen, Beth L.
  • Biochemistry, Vol. 40, Issue 14, p. 4222-4228
  • DOI: 10.1021/bi002172e

Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors
journal, November 1998


Lead discovery using molecular docking
journal, August 2002

  • Shoichet, Brian K.; McGovern, Susan L.; Wei, Binqing
  • Current Opinion in Chemical Biology, Vol. 6, Issue 4, p. 439-446
  • DOI: 10.1016/S1367-5931(02)00339-3

Discovering High-Affinity Ligands for Proteins: SAR by NMR
journal, November 1996


Direct Antilymphoma Activity of Novel, First-Generation "Antibody Mimics" that Bind HLA-DR10-Positive Non-Hodgkin's Lymphoma Cells
journal, December 2006

  • West, Jeremy; Perkins, Julie; Hok, Saphon
  • Cancer Biotherapy and Radiopharmaceuticals, Vol. 21, Issue 6, p. 645-654
  • DOI: 10.1089/cbr.2006.21.645